ACM
Ashford Capital Management’s Harmony Biosciences HRMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-434,148
| Closed | -$14.2M | – | 94 |
|
|
2023
Q3 | $14.2M | Sell |
434,148
-14,890
| -3% | -$488K | 2.09% | 21 |
|
|
2023
Q2 | $15.8M | Buy |
449,038
+3,620
| +0.8% | +$127K | 2.21% | 21 |
|
|
2023
Q1 | $14.5M | Buy |
445,418
+88,780
| +25% | +$2.9M | 2.18% | 19 |
|
|
2022
Q4 | $19.7M | Sell |
356,638
-134,130
| -27% | -$7.39M | 3.05% | 13 |
|
|
2022
Q3 | $21.7M | Sell |
490,768
-176,480
| -26% | -$7.82M | 3.32% | 8 |
|
|
2022
Q2 | $32.5M | Buy |
667,248
+7,375
| +1% | +$360K | 4.62% | 4 |
|
|
2022
Q1 | $32.1M | Sell |
659,873
-34,910
| -5% | -$1.7M | 3.46% | 8 |
|
|
2021
Q4 | $29.6M | Buy |
694,783
+64,310
| +10% | +$2.74M | 2.95% | 10 |
|
|
2021
Q3 | $24.2M | Sell |
630,473
-7,560
| -1% | -$290K | 2.2% | 16 |
|
|
2021
Q2 | $18M | Sell |
638,033
-8,640
| -1% | -$244K | 1.62% | 32 |
|
|
2021
Q1 | $21.4M | Buy |
646,673
+373,723
| +137% | +$12.3M | 2% | 23 |
|
|
2020
Q4 | $9.87M | Buy |
+272,950
| New | +$9.87M | 0.95% | 36 |
|